Recent Advances of Liquid Biopsy for Bladder Cancer Diagnosing

doi:10.11944/j.issn.1000-0518.2019.04.180412

Chinese Journal of Applied Chemistry ›› 2019, Vol. 36 ›› Issue (4): 367-378.DOI: 10.11944/j.issn.1000-0518.2019.04.180412

• Review • Previous Articles Next Articles

Recent Advances of Liquid Biopsy for Bladder Cancer Diagnosing

ZENG Bo^a,YANG Yanbing^a,LIANG Ling^b,YUAN Quan^a^*()

^aCollege of Chemistry and Molecular Sciences,Wuhan University,Wuhan 430072,China
^bMolecular Science and Biomedicine Laboratory(MBL),Institute of Chemical Biology and Nanomedicine,College of Chemistry and Chemical Engineering, Hunan University,Changsha 410082,China

Received:2018-12-27 Accepted:2019-02-03 Published:2019-04-01 Online:2019-04-02
Contact: YUAN Quan
Supported by:
Supported by the National Natural Science Foundation of China(No.21675120), the National Key Research and Development Program of China(No.2017YFA0208000), the Foundation for Innovative Research Groups of NSFC(No.21521063),

Abstract

Abstract:

Bladder cancer is a kind of malignant tumor with high morbidity and mortality. Usually, it only can be diagnosed at the middle or late stage, causing serious physical and mental harm to patients. Cystoscopy is the gold standard for the diagnosis of bladder cancer. However, cystoscopy is invasive to some extent. The limited sensitivity and specificity of cystoscopy are also main barriers for achieving the required early and precise diagnosis of bladder cancer. The occurrence of bladder cancer would have a significant impact on the components of blood and urine. In this regard, non-invasive liquid biopsy shows great potential for realizing early bladder cancer diagnosis. This review describes the development of liquid biopsy-based diagnostic methods for bladder cancer. The main biomarkers of bladder cancer are briefly introduced. The diagnostic methods and mechanisms of bladder cancer with liquid(such as urine and blood) as the detection objects are comprehensively discussed. In addition, the opportunities and challenges of liquid biopsy for bladder cancer diagnosis are recommended. We hope this review will provide guidance for bladder cancer-based liquid biopsy techniques.

Key words: bladder cancer diagnosis, liquid biopsy, ultraviolet-visible absorption spectrum, fluorescence spectrum, electrochemiluminescence, electrochemical sensing

ZENG Bo,YANG Yanbing,LIANG Ling,YUAN Quan. Recent Advances of Liquid Biopsy for Bladder Cancer Diagnosing[J]. Chinese Journal of Applied Chemistry, 2019, 36(4): 367-378.

References

[1]	Dal Moro F,Valotto C,Guttilla A,et al. Urinary Markers in the Everyday Diagnosis of Bladder Cancer[J]. Urologia,2013,80(4):265-275.
[2]	Cheng L,Davison D D,Adams J,et al. Biomarkers in Bladder Cancer:Translational and Clinical Implications[J]. Crit Rev Oncol Hematol,2014,89(1):73-111.
[3]	Elsen S,Lerut E,Van Cleynenbreugel B,et al. Biodistribution of Evans Blue in an Orthotopic AY-27 Rat Bladder Urothelial Cell Carcinoma Model:Implication for the Improved Diagnosis of Non-Muscle-Invasive Bladder Cancer(NMIBC) Using Dye-Guided White-Light Cystoscopy[J]. BJU Int,2015,116(3):468-477.
[4]	Christensen E,Birkenkamp-Demtroder K,Nordentoft I,et al. Liquid Biopsy Analysis of FGFR3 and PIK3CA Hotspot Mutations for Disease Surveillance in Bladder Cancer[J]. Eur Urol,2017,71(6):961-969.
[5]	Costa V L,Henrique R,Danielsen S A,et al. Three Epigenetic Biomarkers, GDF15, TMEFF2, and VIM, Accurately Predict Bladder Cancer from DNA-based Analyses of Urine Samples[J]. Clin Cancer Res,2010,16(23):5842-5851.
[6]	Lei T,Zhao X,Jin S,et al. Discovery of Potential Bladder Cancer Biomarkers by Comparative Urine Proteomics and Analysis[J]. Clin Genitourin Cancer,2013,11(1):56-62.
[7]	Weikert S,Krause H,Wolff I,et al. Quantitative Evaluation of Telomerase Subunits in Urine as Biomarkers for Noninvasive Detection of Bladder Cancer[J]. Int J Cancer,2005,117(2):274-280.
[8]	Xylinas E,Kluth L A,Rieken M,et al. Urine Markers for Detection and Surveillance of Bladder Cancer[J]. Urol Oncol,2014,32(3):222-229.
[9]	Goodison S,Rosser C J,Urquidi V.Bladder Cancer Detection and Monitoring: Assessment of Urine- and Blood-based Marker Tests[J]. Mol Diagn Ther,2013,17(2):71-84.
[10]	Sanli O,Dobruch J,Knowles M A,et al. Bladder Cancer[J]. Nat Rev Dis Primers,2017,3:17022.
[11]	Dobruch J,Daneshmand S,Fisch M,et al. Gender and Bladder Cancer:A Collaborative Review of Etiology, Biology, and Outcomes[J]. Eur Urol,2016,69(2):300-310.
[12]	Babjuk M,Oosterlinck W,Sylvester R,et al. EAU Guidelines on Non-Muscle-Invasive Urothelial Carcinoma of the Bladder, the 2011 Update[J]. Eur Urol,2011,59(6):997-1008.
[13]	Kamat A M,Hahn N M,Efstathiou J A,et al. Bladder Cancer[J]. The Lancet,2016,388(10061):2796-2810.
[14]	Roupret M,Babjuk M,Comperat E,et al. European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2017 Update[J]. Eur Urol,2018,73(1): 111-122.
[15]	Ke Z,Lai Y,Ma X,et al. Diagnosis of Bladder Cancer from the Voided Urine Specimens Using Multi-Target Fluorescence in Situ Hybridization[J]. Oncol Lett,2014,7(2):325-330.
[16]	Horstmann M,Patschan O,Hennenlotter J,et al. Combinations of Urine-based Tumour Markers in Bladder Cancer Surveillance[J]. Scand J Urol Nephrol,2009,43(6):461-466.
[17]	Urquidi V,Kim J,Chang M R,et al. CCL18 in a Multiplex Urine-based Assay for the Detection of Bladder Cancer[J]. Plos One,2012,7(5):e37797.
[18]	Ritter R,Hennenlotter J,Kuhs U,et al. Evaluation of a New Quantitative Point-of-Care Test Platform for Urine-based Detection of Bladder Cancer[J]. Urol Oncol,2014,32(3):337-344.
[19]	Roobol M J,Haese A,Bjartell A.Tumour Markers in Prostate Cancer III:Biomarkers in Urine[J]. Acta Oncol,2011,50:85-89.
[20]	Birkenkamp-Demtroder K,Christensen E,Nordentoft I,et al. Monitoring Treatment Response and Metastatic Relapse in Advanced Bladder Cancer by Liquid Biopsy Analysis[J]. Eur Urol,2018,73(4):535-540.
[21]	Di Meo A,Bartlett J,Cheng Y,et al. Liquid Biopsy:A Step Forward Towards Precision Medicine in Urologic Malignancies[J]. Mol Cancer,2017,16(1):80.
[22]	Chung W,Bondaruk J,Jelinek J,et al. Detection of Bladder Cancer Using Novel DNA Methylation Biomarkers in Urine Sediments[J]. Cancer Epidemiol,2011,20(7):1483-1491.
[23]	Eissa S,Habib H,Ali E,et al. Evaluation of Urinary Mirna-96 as a Potential Biomarker for Bladder Cancer Diagnosis[J]. Med Oncol,2015,32(1):413.
[24]	Bryan R T,Shimwell N J,Wei W,et al. Urinary EpCAM in Urothelial Bladder Cancer Patients: Characterisation and Evaluation of Biomarker Potential[J]. Br J Cancer,2014,110(3):679-685.
[25]	Menendez V,Fernandez-Suarez A,Galan J A,et al. Diagnosis of Bladder Cancer by Analysis of Urinary Fibronectin[J]. Urology,2005,65(2):284-289.
[26]	Sartini D,Muzzonigro G,Milanese G,et al. Upregulation of Tissue and Urinary Nicotinamide N-Methyltransferase in Bladder Cancer:Potential for the Development of a Urine-based Diagnostic Test[J]. Cell Biochem Biophys,2013,65(3):473-483.
[27]	Yang D,Song X,Zhang J,et al. Therapeutic Potential of siRNA-Mediated Combined Knockdown of the IAP Genes(Livin, XIAP, and Survivin) on Human Bladder Cancer T24 Cells[J]. Acta Biochim Biophys Sin,2010,42(2):137-144.
[28]	Duan R,Wang B,Zhang T,et al. Sensitive and Bidirectional Detection of Urine Telomerase Based on the Four Detection-Color States of Difunctional Gold Nanoparticle Probe[J]. Anal Chem,2014,86(19):9781-9785.
[29]	Li X,Wang Y,Xu J,et al. Sandwich ELISA for Detecting Urinary Survivin in Bladder Cancer[J]. Chinese J Cancer Res,2013,25(4):375-381.
[30]	May M,Hakenberg O W,Gunia S,et al. Comparative Diagnostic Value of Urine Cytology, UBC-ELISA, and Fluorescence in Situ Hybridization for Detection of Transitional Cell Carcinoma of Urinary Bladder in Routine Clinical Practice[J]. Urology,2007,70(3):449-453.
[31]	Konety B R,Nguyen T S T,Brenes G,et al. Clinical Usefulness of the Novel Marker BLCA-4 for the Detection of Bladder Cancer[J]. J Urol,2000,164(3):634-639.
[32]	Cheng L,Davison D D,Adams J,et al. Biomarkers in Bladder Cancer:Translational and Clinical Implications[J]. Crit Rev Oncol Hematol,2014,89(1):73-111.
[33]	Goodison S,Rosser C J,Urquidi V.Bladder Cancer Detection and Monitoring:Assessment of Urine- and Blood-based Marker Tests[J]. Mol Diagn Ther,2013,17(2):71-84.
[34]	Ritter R,Hennenlotter J,Kuhs U,et al. Evaluation of a New Quantitative Point-of-Care Test Platform for Urine-based Detection of Bladder Cancer[J]. Urol Oncol-Semin Ori,2014,32(3):337-344.
[35]	Wang J,Wang Y,Hu X,et al. Dual-Aptamers-Conjugated Molecular Modulator for Detecting Bioactive Metal Ions and Inhibiting Metal-Mediated Protein Aggregation[J]. Anal Chem,2019,91(1):823-829.
[36]	Li D,Liang L,Tang Y W,et al. Direct and Single-Step Sensing of Primary Ovarian Cancers Related Glycosidases[J]. Chinese Chem Lett,2018,DOI:
[37]	Tan Y,Hu X,Liu M,et al. Simultaneous Visualization and Quantitation of Multiple Steroid Hormones Based on Signal-Amplified Biosensing with Duplex Molecular Recognition[J]. Chem Eur J,2017,23(44):10683-10689.
[38]	Yao Q,Wang Y,Wang J,et al. An Ultrasensitive Diagnostic Biochip Based on Biomimetic Periodic Nanostructure-Assisted Rolling Circle Amplification[J]. ACS Nano,2018,12(7):6777-6783.
[39]	Huang C,Wang J,Lv X,et al. Redefining Molecular Amphipathicity in Reversing the “Coffee-Ring Effect”:Implications for Single Base Mutation Detection[J]. Langmuir,2018,34(23):6777-6783.
[40]	Wang J,Ma Q,Zheng W,et al. One-Dimensional Luminous Nanorods Featuring Tunable Persistent Luminescence for Autofluorescence-Free Biosensing[J]. ACS Nano,2017,11(8):8185-8191.
[41]	Hu X,Wang Y,Liu H,et al. Naked Eye Detection of Multiple Tumor-Related mRNAs from Patients with Photonic-Crystal Micropattern Supported Dual-Modal Upconversion Bioprobes[J]. Chem Sci,2017,8(1):466-472.
[42]	He A,Liu T C,Dong Z N,et al. A Novel Immunoassay for the Quantization of CYFRA 21-1 in Human Serum[J]. J Clin Lab Anal,2013,27(4):277-283.
[43]	Lou X,Zhuang Y,Zuo X,et al. Real-Time, Quantitative Lighting-up Detection of Telomerase in Urines of Bladder Cancer Patients by AIEgens[J]. Anal Chem,2015,87(13):6822-6827.
[44]	Duan R,Zhang Z,Zheng F,et al. Combining Protein and miRNA Quantification for Bladder Cancer Analysis[J]. ACS Appl Mater Interfaces,2017,9(28):23420-23427.
[45]	Zhuang Y,Xu Q,Huang F,et al. Ratiometric Fluorescent Bioprobe for Highly Reproducible Detection of Telomerase in Bloody Urines of Bladder Cancer Patients[J]. ACS Sens,2016,1(5):572-578.
[46]	Gogalic S,Sauer U,Doppler S,et al. Bladder Cancer Biomarker Array to Detect Aberrant Levels of Proteins in Urine[J]. Analyst,2015,140(3):724-735.
[47]	Bubendorf L.Multiprobe Fluorescence in Situ Hybridization(UroVysion) for the Detection of Urothelial Carcinoma-FISHing for the Right Catch[J]. Acta Cytol,2011,55(2):113-119.
[48]	Wu L,Wang J,Feng L,et al. Label-free Ultrasensitive Detection of Human Telomerase Activity Using Porphyrin-Functionalized Graphene and Electrochemiluminescence Technique[J]. Adv Mater,2012,24(18):2447-2452.
[49]	Yang Y B,Yang X D,Zou X M,et al. Ultrafine Graphene Nanomesh with Large On/Off Ratio for High-Performance Flexible Biosensors[J]. Adv Funct Mater,2017,27(19):1604096.
[50]	Han T Q,Li X J,Li Y Y,et al. Gold Nanoparticles Enhanced Electrochemiluminescence of Graphite-Like Carbon Nitride for the Detection of Nuclear Matrix Protein 22[J]. Sens Actuators,B,2014,205:176-183.
[51]	Ma H,Zhang X,Li X,et al. Electrochemical Immunosensor for Detecting Typical Bladder Cancer Biomarker Based on Reduced Graphene Oxide-Tetraethylene Pentamine and Trimetallic AuPdPt Nanoparticles[J]. Talanta,2015,143:77-82.
[52]	Wu D,Wang Y,Zhang Y,et al. Sensitive Electrochemical Immunosensor for Detection of Nuclear Matrix Protein-22 Based on NH2-SAPO-34 Supported Pd/Co Nanoparticles[J]. Sci Rep,2016,6:24551.
[53]	Liu Y J,Wei M,Liu X,et al. Label-Free Ultrasensitive Detection of Telomerase Activity via Multiple Telomeric Hemin/G-Quadruplex Triggered Polyaniline Deposition and a DNA Tetrahedron-Structure Regulated Signal[J]. Chem Commun,2016,52(9):1796-1799.
[54]	Jia H,Gao P,Ma H,et al. Preparation of Au-Pt Nanostructures by Combining Top-Down with Bottom-Up Strategies and Application in Label-Free Electrochemical Immunosensor for Detection of NMP22[J]. Bioelectrochemistry,2015,101:22-27.
[55]	Wang J,Shen H J,Huang C,et al. Highly Efficient and Multidimensional Extraction of Targets from Complex Matrices Using Aptamer-Driven Recognition[J]. Nano Res,2016,10(1):145-156.
[56]	Li N,Wang Y L,Li Y Y,et al. A Label-Free Electrochemical Immunosensor Based on Au@Pd/Ag Yolk-Bimetallic Shell Nanoparticles and Amination Graphene for Detection of Nuclear Matrix Protein 22[J]. Sens Actuators,B,2014,202:67-73.
[57]	Eissa S,Badr S,Barakat M,et al. The Diagnostic Efficacy of Urinary Survivin and Hyaluronidase mRNA as Urine Markers in Patients with Bladder Cancer[J]. Clin Lab,2013,59(7/8):893-900.
[58]	Eissa S,Swellam M,Shehata H,et al. Expression of HYAL1 and Survivin RNA as Diagnostic Molecular Markers for Bladder Cancer[J]. J Urol,2010,183(2):493-498.
[59]	Lu W,Wang J,Wu Q,et al. High-throughput Sample-to-Answer Detection of DNA/RNA in Crude Samples Within Functionalized Micro-pipette Tips[J]. Biosen Bioelectron,2016,75:28-33.
[60]	Lu W,Chen Y,Liu Z,et al. Quantitative Detection of MicroRNA in One Step via Next Generation Magnetic Relaxation Switch Sensing[J]. ACS Nano,2016,10(7):6685-6692.
[61]	Yosef H K,Krauss S D,Lechtonen T,et al. Noninvasive Diagnosis of High-Grade Urothelial Carcinoma in Urine by Raman Spectral Imaging[J]. Anal Chem,2017,89(12):6893-6899.
[62]	Lin H K,Zheng S,Williams A J,et al. Portable Filter-based Microdevice for Detection and Characterization of Circulating Tumor Cells[J]. Clin Cancer Res,2010,16(20):5011-5018.
[63]	Appel J H,Ren H,Sin M L Y,et al. Rapid Bladder Cancer Cell Detection from Clinical Urine Samples Using an Ultra-thin Silicone Membrane[J]. Analyst,2016,141(2):652-660.
[64]	Wen H,Lee T,You S,et al. Urinary Metabolite Profiling Combined with Computational Analysis Predicts Interstitial Cystitis-Associated Candidate Biomarkers[J]. J Proteome Res,2015,14(1):541-548.
[65]	Yu T,Dai P P,Xu J J,et al. Highly Sensitive Colorimetric Cancer Cell Detection Based on Dual Signal Amplification[J]. ACS Appl Mater Interfaces,2016,8(7):4434-4441.
[66]	Jeong S,Park Y,Cho Y,et al. Diagnostic Values of Urine CYFRA21-1, NMP22, UBC, and FDP for the Detection of Bladder Cancer[J]. Clin Chim Acta,2012,414:93-100.
[67]	Kibar Y,Goktas S,Kilic S,et al. Prognostic Value of Cytology, Nuclear Matrix Protein 22(NMP22) Test, and Urinary Bladder Cancer II(UBC II) Test in Early Recurrent Transitional Cell Carcinoma of the Bladder[J]. Ann Clin Lab Sci,2006,36(1):31-38.
[68]	Mian C,Lodde M,Haitel A,et al. Comparison of the Monoclonal UBC-ELISA Test and the NMP22 ELISA Test for the Detection of Urothelial Cell Carcinoma of the Bladder[J]. Urology,2000,55(2):223-226.
[69]	Giannopoulos A,Manousakas T,Gounari A,et al. Comparative Evaluation of the Diagnostic Performance of the BTA Stat Test, NMP22 and Urinary Bladder Cancer Antigen for Primary and Recurrent Bladder Tumors[J]. J Urology,2001,166(2):470-475.
[70]	Sullivan P S,Nooraie F,Sanchez H,et al. Comparison of ImmunoCyt, UroVysion, and Urine Cytology in Detection of Recurrent Urothelial Carcinoma:A “Split-Sample” Study[J]. Cancer,2009,117(3):167-173.

Recent Advances of Liquid Biopsy for Bladder Cancer Diagnosing

RichHTML

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	XIONG Hai-Tao, WU Rui, WU Ying-Chun. Electrochemiluminescence Determination of Carbamazepine Based on the Nafion-Carbon Nanotube Modified Electrode [J]. Chinese Journal of Applied Chemistry, 2021, 38(6): 731-738.
[2]	WEI Guobing,KONG Derong,XU Huihui,YIN Zhaojiang,ZHANG Jing,CUI Hanfeng,HONG Nian,YANG Jie,XIONG Wei,LIU Wenming,GUO Qianwen,CHENG Lin,FAN Hao. A New Type of Electrochemiluminescence Sensor for Detection of Mercury Ion in Chinese Medicinal Materials Danshen Based on Host-Guest Interaction [J]. Chinese Journal of Applied Chemistry, 2019, 36(5): 595-602.
[3]	ZHANG Jiayi,LUO Lijun,LIU Xiaohong,LI Libo,CHENG Liang,CAO Dawei,YOU Tianyan. Research Progress of Electrochemiluminescence Sensors in the Field of Agricultural Sensing [J]. Chinese Journal of Applied Chemistry, 2019, 36(4): 379-391.
[4]	QIN Xiaoli,WANG Minghan,DONG Yifan,SHAO Yuanhua. Electrochemiluminescent Biosensing and Its Application in Rapid Detection of Acute Myocardial Infarction Markers [J]. Chinese Journal of Applied Chemistry, 2018, 35(9): 1107-1112.
[5]	GAO Lifang,SONG Zhongqian,SUN Zhonghui,LI Fenghua,HAN Dongxue,NIU Li. Application and Development of Novel Two-Dimensional Nanomaterials in Electrochemistry [J]. Chinese Journal of Applied Chemistry, 2018, 35(3): 247-258.
[6]	CHEN Liwei,HAN Qing,ZHANG Huimin,QU Liangti. Preparation of Graphene-Based Microelectrode and Its Application in Electrochemical Sensing [J]. Chinese Journal of Applied Chemistry, 2018, 35(3): 286-298.
[7]	GENG Shaoguang, JIANG Xiaoying, CUI Fengling*, SHI Lei. Determination of Protein in Biological Samples Using a Thiosemicarbazone Derivative as a Fluorescence Probe [J]. Chinese Journal of Applied Chemistry, 2013, 30(05): 555-559.
[8]	XIONG Xiaoqin*, ZHAI Qiuge, XUE Lingfen, ZHENG Fei, XIE Xu. Synthesis of Styrylpyrimidine and Its Spectral Characteristic as a pH Probe [J]. Chinese Journal of Applied Chemistry, 2012, 29(11): 1262-1265.
[9]	CUI Fengling*, HUO Ruina, ZHANG Guisheng, XING Weiwei. Fluorescence Spectrometry on the Interaction of 4′-O-(α-L-oleandrosyl)daunorubicin with Calf Thymus DNA [J]. Chinese Journal of Applied Chemistry, 2012, 29(02): 238-244.
[10]	WANG Shu-Jun. Axial Coordination Reaction Between Nitryl Phenyl Zn Porphyrin and Imidazole Derivatives Studied by Spectroscopic Method [J]. Chinese Journal of Applied Chemistry, 2010, 27(06): 721-726.
[11]	GUO Li-Min, GUO Xiang-Feng*, JIA Li-Hua, SUN Shu-Jun. Simultaneous Determination of 1-Naphylamine and 2-Naphylamine by Derivative Synchronous Fluorescent Method [J]. Chinese Journal of Applied Chemistry, 2010, 27(05): 611-614.
[12]	. Synthesis and electrochemiluminescent study of a novel ruthenium complex [Rubis(bipyridyl) (3,4,7,8-tetrachrolo-1,10-phenanthroline)](PF6)2 [J]. Chinese Journal of Applied Chemistry, 2009, 26(6): 726-729.
[13]	ZHANG Jian, QIU Yu, YU Dao-Yong*. Critical Micelle Concentration Determination of Sodium Dodecyl Benzene Sulfonate by Synchronous Fluorescence Spectrometry [J]. Chinese Journal of Applied Chemistry, 2009, 26(12): 1480-1483.
[14]	XUE Ling-Wei1,2, PENG Qi-Long1, HAN Yong-Jun1, XUE Zhi2, HOU An-Xin2*. Synthesis of a novel diselenide porphyrins dimers and Its Interaction with BSA [J]. Chinese Journal of Applied Chemistry, 2009, 26(08): 909-912.
[15]	Chen Ji, Ma Genxiang, Li Xiaojing, Zhang Shugong, Li Deqian. Fluorescence Spectrometric Study on the Suppression of Ge-132 on Maillard Reaction of Phenylalanine [J]. Chinese Journal of Applied Chemistry, 1998, 0(6): 89-91.